Bilirubin-A Possible Prognostic Mortality Marker for Patients with ECLS

Overview

Journal J Clin Med

Specialty General Medicine

Date 2020 Jun 7

PMID 32503278

Citations 4

Authors

Sebastian Bunte

Roland Walz

Julia Merkel

Carolin Torregroza

Sebastian Roth

Giovanna Lurati Buse

Hannan Dalyanoglu

Payam Akhyari

Artur Lichtenberg

Markus W Hollmann

Hug Aubin

Ragnar Huhn

Affiliations

Soon will be listed here.

Abstract

Extracorporeal life support (ECLS) is a promising therapeutic option for patients with refractory cardiogenic shock. However, as the mortality rate still remains high, there is a need for early outcome parameters reflecting therapy success or futility. Therefore, we investigated whether liver enzyme levels could serve as prognostic mortality markers for patients with ECLS. The present study is a retrospective single-center cohort study. Adult patients >18 years of age who received ECLS therapy between 2011 and 2018 were included. Bilirubin, glutamic-oxaloacetic transaminase (GOT), and glutamic-pyruvic-transaminase (GPT) serum levels were analyzed at day 5 after the start of the ECLS therapy. The primary endpoint of this study was all-cause in-hospital mortality. A total of 438 patients received ECLS during the observation period. Based on the inclusion criteria, 298 patients were selected for the statistical analysis. The overall mortality rate was 42.6% ( = 127). The area under the curve (AUC) in the receiver operating characteristic curve (ROC) for bilirubin on day 5 was 0.72 (95% confidence interval (CI): 0.66-0.78). Cox regression with multivariable adjustment revealed a significant association between bilirubin on day 5 and mortality, with a hazard ratio (HR) of 2.24 (95% CI: 1.53-3.30). Based on the results of this study, an increase in serum bilirubin on day 5 of ECLS therapy correlates independently with mortality.

Citing Articles

Dexmedetomidine as a cardioprotective drug: a narrative review.

Takahashi K, Yoshikawa Y, Kanda M, Hirata N, Yamakage M J Anesth. 2023; 37(6):961-970.

PMID: 37750978 DOI: 10.1007/s00540-023-03261-w.

Machine-learning based prediction of prognostic risk factors in patients with invasive candidiasis infection and bacterial bloodstream infection: a singled centered retrospective study.

Li Y, Wu Y, Gao Y, Niu X, Li J, Tang M BMC Infect Dis. 2022; 22(1):150.

PMID: 35152879 PMC: 8841094. DOI: 10.1186/s12879-022-07125-8.

Hemoadsorption in 'Liver Indication'-Analysis of 109 Patients' Data from the CytoSorb International Registry.

Ocskay K, Tomescu D, Faltlhauser A, Jacob D, Friesecke S, Malbrain M J Clin Med. 2021; 10(21).

PMID: 34768702 PMC: 8584981. DOI: 10.3390/jcm10215182.

Fibrinogen-Albumin-Ratio is an independent predictor of thromboembolic complications in patients undergoing VA-ECMO.

Roth S, Jansen C, MPembele R, Stroda A, Boeken U, Akhyari P Sci Rep. 2021; 11(1):16648.

PMID: 34404824 PMC: 8371004. DOI: 10.1038/s41598-021-95689-x.

References

Aubin H, Petrov G, Dalyanoglu H, Richter M, Saeed D, Akhyari P . Four-year experience of providing mobile extracorporeal life support to out-of-center patients within a suprainstitutional network-Outcome of 160 consecutively treated patients. Resuscitation. 2017; 121:151-157. DOI: 10.1016/j.resuscitation.2017.08.237. View

Chen Y, Lin J, Yu H, Ko W, Jerng J, Chang W . Cardiopulmonary resuscitation with assisted extracorporeal life-support versus conventional cardiopulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet. 2008; 372(9638):554-61. DOI: 10.1016/S0140-6736(08)60958-7. View

Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J . Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg. 2013; 97(2):610-6. DOI: 10.1016/j.athoracsur.2013.09.008. View

Eisenberg M, Mengert T . Cardiac resuscitation. N Engl J Med. 2001; 344(17):1304-13. DOI: 10.1056/NEJM200104263441707. View

Freundt M, Lunz D, Philipp A, Panholzer B, Lubnow M, Friedrich C . Impact of dynamic changes of elevated bilirubin on survival in patients on veno-arterial extracorporeal life support for acute circulatory failure. PLoS One. 2017; 12(10):e0184995. PMC: 5648125. DOI: 10.1371/journal.pone.0184995. View

Massetti M, Tasle M, Le Page O, Deredec R, Babatasi G, Buklas D . Back from irreversibility: extracorporeal life support for prolonged cardiac arrest. Ann Thorac Surg. 2004; 79(1):178-83. DOI: 10.1016/j.athoracsur.2004.06.095. View

Roedl K, Spiel A, Nurnberger A, Horvatits T, Drolz A, Hubner P . Hypoxic liver injury after in- and out-of-hospital cardiac arrest: Risk factors and neurological outcome. Resuscitation. 2019; 137:175-182. DOI: 10.1016/j.resuscitation.2019.02.038. View

Hajbaghery M, Mousavi G, Akbari H . Factors influencing survival after in-hospital cardiopulmonary resuscitation. Resuscitation. 2005; 66(3):317-21. DOI: 10.1016/j.resuscitation.2005.04.004. View

Doulberis M, Kotronis G, Gialamprinou D, Ozguler O, Exadaktylos A, Oikonomou V . Acute Liver Failure: From Textbook to Emergency Room and Intensive Care Unit With Concomitant Established and Modern Novel Therapies. J Clin Gastroenterol. 2018; 53(2):89-101. DOI: 10.1097/MCG.0000000000001162. View

10.

Benjamin E, Virani S, Callaway C, Chamberlain A, Chang A, Cheng S . Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018; 137(12):e67-e492. DOI: 10.1161/CIR.0000000000000558. View

11.

Burrell A, Pellegrino V, Wolfe R, Wong W, Cooper D, Kaye D . Long-term survival of adults with cardiogenic shock after venoarterial extracorporeal membrane oxygenation. J Crit Care. 2015; 30(5):949-56. DOI: 10.1016/j.jcrc.2015.05.022. View

12.

Aubin H, Petrov G, Dalyanoglu H, Saeed D, Akhyari P, Paprotny G . A Suprainstitutional Network for Remote Extracorporeal Life Support: A Retrospective Cohort Study. JACC Heart Fail. 2016; 4(9):698-708. DOI: 10.1016/j.jchf.2016.03.018. View

13.

Tessier G, Villeneuve E, Villeneuve J . Etiology and outcome of acute liver failure: experience from a liver transplantation centre in Montreal. Can J Gastroenterol. 2002; 16(10):672-6. DOI: 10.1155/2002/328415. View

14.

Roth C, Schrutka L, Binder C, Kriechbaumer L, Heinz G, Lang I . Liver function predicts survival in patients undergoing extracorporeal membrane oxygenation following cardiovascular surgery. Crit Care. 2016; 20:57. PMC: 4788876. DOI: 10.1186/s13054-016-1242-4. View

15.

Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus P . Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015; 36(33):2246-56. DOI: 10.1093/eurheartj/ehv194. View

16.

Iesu E, Franchi F, Zama Cavicchi F, Pozzebon S, Fontana V, Mendoza M . Acute liver dysfunction after cardiac arrest. PLoS One. 2018; 13(11):e0206655. PMC: 6218055. DOI: 10.1371/journal.pone.0206655. View

17.

Pozzi M, Armoiry X, Achana F, Koffel C, Pavlakovic I, Lavigne F . Extracorporeal Life Support for Refractory Cardiac Arrest: A 10-Year Comparative Analysis. Ann Thorac Surg. 2018; 107(3):809-816. DOI: 10.1016/j.athoracsur.2018.09.007. View

18.

Mazzeffi M, Greenwood J, Tanaka K, Menaker J, Rector R, Herr D . Bleeding, Transfusion, and Mortality on Extracorporeal Life Support: ECLS Working Group on Thrombosis and Hemostasis. Ann Thorac Surg. 2015; 101(2):682-9. DOI: 10.1016/j.athoracsur.2015.07.046. View

19.

Thiagarajan R, Barbaro R, Rycus P, McMullan D, Conrad S, Fortenberry J . Extracorporeal Life Support Organization Registry International Report 2016. ASAIO J. 2016; 63(1):60-67. DOI: 10.1097/MAT.0000000000000475. View

20.

Conrad S, Rycus P . Extracorporeal membrane oxygenation for refractory cardiac arrest. Ann Card Anaesth. 2017; 20(Supplement):S4-S10. PMC: 5299827. DOI: 10.4103/0971-9784.197790. View